Recursion Pharmaceuticals, Inc. Public Market Comparables
Find the most relevant public market comparables for Recursion Pharmaceuticals, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. It uses an integrated AI-enabled full-stack platform, the Recursion Operating System (OS), to map and navigate biological and chemical relationships, accelerating the identification of potential drug treatments. The company focuses on oncology and rare diseases.
Business Model
TechBio company utilizing AI and machine learning to accelerate and industrialize drug discovery. This includes an internal drug pipeline, co-development partnerships with major pharmaceutical companies, and building a large proprietary biological and chemical dataset.
Target Customers
Pharmaceutical companies (for partnerships and collaborations), patients (through drug development and commercialization).
Specific Focus
AI-driven drug discovery and development, focusing on oncology and rare diseases.
Location
Salt Lake City, Utah
CEO
Chris Gibson
Industry
Life sciences
Sub Sector
Biotechnology & Drugs
3yr Revenue Growth
1,025%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Recursion Pharmaceuticals, Inc. in the Healthcare sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Recursion Pharmaceuticals, Inc.? Our platform provides detailed analysis of Recursion Pharmaceuticals, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Recursion Pharmaceuticals, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Recursion Pharmaceuticals, Inc. Compset
As a leading player in the Life sciences industry within the Healthcare sector, Recursion Pharmaceuticals, Inc. operates in the specialized Biotechnology & Drugs sub-sector. Understanding how Recursion Pharmaceuticals, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology & Drugs space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
BioCryst Pharmaceuticals Inc.
Biotechnology • Life sciences
BioCryst Pharmaceuticals Inc. is a biotechnology company that designs, optimizes, and develops small molecule drugs to block critical enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary angioedema.
Xeris Biopharma Holdings, Inc.
Biopharmaceutical • Life sciences
A growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, focusing on endocrinology, neurology, and gastroenterology.
Foghorn Therapeutics Inc.
Biotechnology • Life sciences
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company focused on discovering and developing a new class of medicines that target genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform provides a mechanistic understanding of how components of this system interact, enabling the identification and validation of potential drug targets. The company is developing therapies for various cancers, including hematologic cancers and solid tumors.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Recursion Pharmaceuticals, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free